To restore voluntary control of bladder and bowel for people with spinal cord injury, spina bifida,
multiple sclerosis and other neurological conditions.
To provide safe and effective, practical and convenient, “on demand” pharmaceutical agents that trigger voiding of bladder and/or bowel contents when the person wishes. This involves the identification and development of pharmaceutical agents combined with various drug delivery technologies. By focusing on well-established biological targets and “repositioning” compounds that are safe, we increase speed to market, reduce development costs, and reduce risk.